Oxidoreductive Balance and Lysosomal Activity in Cancer Patients.

CompletedOBSERVATIONAL
Enrollment

83

Participants

Timeline

Start Date

June 19, 2017

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
NeoplasmsAntioxidantsOxidative StressLipid PeroxidationInflammationLysosome Alteration
Interventions
DIAGNOSTIC_TEST

Patients

The FDG PET/CT imaging will be performed as part of typical medical procedures related to the diagnosis and monitoring of cancers at the Oncology Center in Bydgoszcz, Poland

Trial Locations (3)

85-092

The Chair of Medical Biology, Collegium Medicum of Nicolaus Copernicus University, Bydgoszcz

85-796

Department of Nuclear Medicine of Center Oncology in Bydgoszcz, Bydgoszcz

Department of Positron Emission Tomography and Molecular Diagnostics, Collegium Medicum of Nicolaus Copernicus University, Bydgoszcz

All Listed Sponsors
lead

Nicolaus Copernicus University

OTHER

NCT03470857 - Oxidoreductive Balance and Lysosomal Activity in Cancer Patients. | Biotech Hunter | Biotech Hunter